Linoleic Acid and Risk of Type 2 Diabetes
Riccardi G
The Lancet Diabetes & Endocrinology. Pub. online 11 October 2017
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Omega-6 Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of Individual-Level Data For 39 740 Adults From 20 Prospective Cohort Studies
Wu JHY, Marklund M, Imamura F, et al.
The Lancet Diabetes & Endocrinology. Pub. online 11 October 2017
Leggi
Vascular Complications in Diabetes: Old Messages, New Thoughts
Forbes JM, Fotheringham AK
Diabetologia. 2017;60(11):2129-38
Leggi
Effect of Population Screening for Type 2 Diabetes And Cardiovascular Risk Factors On Mortality Rate And Cardiovascular Events: A Controlled Trial Among 1,912,392 Danish Adults
Simmons RK, Griffin SJ, Witte DR, et al.
Diabetologia. 2017;60(11):2183-91
Leggi
Effect of Screening for Type 2 Diabetes On Risk Of Cardiovascular Disease And Mortality: A Controlled Trial Among 139,075 Individuals Diagnosed With Diabetes In Denmark Between 2001 And 2009
Simmons RK, Griffin SJ, Lauritzen T, et al.
Diabetologia. 2017;60(11):2192-9
Leggi
Inpatient Glucose Values: Determining the Nondiabetic Range and Use in Identifying Patients at High Risk for Diabetes
Rhee MK, Safo SE, Jackson SLM, et al.
The American Journal of Medicine. Pub. online: October 6, 2017
Leggi
Exenatide Once Weekly Versus Placebo in Parkinson’s Disease: A Randomised, Double-Blind, Placebo-Controlled Trial
Athauda D, Maclagan K, Skene SS, et al.
The Lancet. 2017;390(10103):1664-75
Leggi
Insulin Signalling: New Target for Parkinson’s Treatments?
Poewe W, Seppi K
The Lancet. 2017;390(10103):1628-30
Leggi
Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus
Ernande L, Audureau E, Jellis CL, et al.
J Am Coll Cardiol 2017;70(14):1704-16
Leggi
Cardiac Involvement in DiabetesThe Dark Side of the Moon
Galderisi M, Esposito R, Trimarco B
J Am Coll Cardiol 2017;70(14):1717-9
Leggi